SEATTLE--(BUSINESS WIRE)--Dec. 2, 2005--Alder Biopharmaceuticals Inc., an emerging antibody therapeutics company, today announced a broad collaborative alliance with Schering-Plough, a leading pharmaceutical company. The collaboration will use Alder’s proprietary yeast production system and high throughput antibody selection system to identify and produce antibodies more rapidly and cost effectively.
